Post-authorisation safety study (PASS) to evaluate risk minimisation measures for medication errors with Uptravi during the titration phase in patients with pulmonary arterial hypertension (PAH) in clinical practice (EDUCATE) First published 15/10/2018 Last updated 15/04/2026 EU PAS number:EUPAS25699 Study Ongoing